Research Topics
Species | Lina MateraSummaryAffiliation: University of Turin Country: Italy Publications
| Collaborators
|
Detail Information
Publications
In vitro maturation of dendritic cells from blood progenitorsLina Matera
Laboratory of Tumor Immunology, Department of Internal Medicine, University of Turin, Italy
Methods Mol Biol 215:417-26. 2003- Effect of prolactin on the antigen presenting function of monocyte-derived dendritic cellsL Matera
Department of Internal Medicine, University of Turin, Italy
Lupus 10:728-34. 2001.... - The choice of the antigen in the dendritic cell-based vaccine therapy for prostate cancerLina Matera
Laboratory of Tumor Immunology, Department of Internal Medicine, University of Turin, Turin, Italy
Cancer Treat Rev 36:131-41. 2010..In advanced stages, vaccine can still be effective when combined with systemic or local cytoreductive therapies, which may overcome antigen specific tolerance and subvert the tumor immunosuppressive environment... - Increased expression of HSP70 by colon cancer cells is not always associated with access to the dendritic cell cross-presentation pathwayLina Matera
Deptartment of Internal Medicine, University of Turin, Italy
Cell Mol Biol Lett 12:268-79. 2007..Of the three CTL-generating tumors, only one expressed hsp70. This data indicates a tumor-specific expression of hsp70, but does not support its relevance in the DC cross-presentation of TAs... - Nitric oxide and P-glycoprotein modulate the phagocytosis of colon cancer cellsJoanna Kopecka
Department of Genetics, Biology and Biochemistry, University of Turin, Via Santena 5 bis, Turin, Italy
J Cell Mol Med 15:1492-504. 2011..Our work suggests that the levels of nitric oxide and Pgp critically modulate the recognition of the tumour cells by dendritic cells, and proposes a new potential therapeutic approach against chemo-immunoresistant tumours... - Drug- and cell-mediated antitumor cytotoxicities modulate cross-presentation of tumor antigens by myeloid dendritic cellsAlessandra Galetto
Department of Oncology, Centro OncoEmatologicoSubalpino (COES, University of Turin, Italy
Anticancer Drugs 14:833-43. 2003..Together, these data indicate that apoptotic death induced by anti-cancer therapies can induce distinct patterns of class I MHC cross-presentation of gastric carcinoma-associated antigens to cytotoxic T lymphocyte precursors... - iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cellsSara De Boo
Department of Genetics, Biology and Biochemistry, University of Turin, Via Santena 5 bis, 10126 Turin, Italy
Mol Cancer 8:108. 2009..To clarify this issue, we compared the doxorubicin-sensitive human colon cancer HT29 cells with the drug-resistant HT29-dx cells and the HT29 cells silenced for iNOS (HT29 iNOS-)... - Immunogenicity of 56 degrees C and UVC-treated prostate cancer is associated with release of HSP70 and HMGB1 from necrotic cellsDavide Brusa
Laboratory of Tumor Immunology, Department of Internal Medicine, University of Turin, Turin, Italy
Prostate 69:1343-52. 2009..Prostate hyperthermia and photodynamic therapy can be delivered by a variety of procedures which result in a wide range of temperatures and light energy and cause different kinds of cell death... - Post-apoptotic tumors are more palatable to dendritic cells and enhance their antigen cross-presentation activityDavide Brusa
Laboratory of Tumor Immunology, Department of Internal Medicine, University of Turin, Turin, Italy
Vaccine 26:6422-32. 2008..These data offer a description of the molecular and immunogenic characteristics of post-apoptotic tumors which can be exploited to increase the efficiency of in vivo and ex vivo TAA delivery to the DC cross-presentation pathway... - Contribution of dendritic cells' FcgammaRI and FcgammaRIII to cross-presentation of tumor cells opsonized with the anti-MHC class I monoclonal antibodiesElena Signorino
Laboratory of Tumor Immunology, University of Turin, Turin, Italy
Cancer Biol Ther 6:1932-7. 2007.... - Binding of prostate-specific membrane antigen to dendritic cells: a critical step in vaccine preparationStefano Garetto
Laboratory of Tumor Immunology, Department of Internal Medicine, University of Turin, Turin, Italy
Cytotherapy 11:1090-100. 2009..We evaluated the actual binding of selected HLA-A2-restricted PSMA peptides to HLA class I molecules on ex vivo-generated mature (m) DC... - Influence of drug-induced apoptotic death on processing and presentation of tumor antigens by dendritic cellsStefano Buttiglieri
Department of Oncology, Centro OncoEmatologicoSubalpino (COES, Turin, Italy
Int J Cancer 106:516-20. 2003.... - Correlation between NK function and response to trastuzumab in metastatic breast cancer patientsAlessandra Beano
Dept of Medical Oncology, Molinette s Hospital, Turin, Italy, 2Laboratory of Tumour Immunology, Dept of Internal Medicine, Universityof Turin, Italy
J Transl Med 6:25. 2008..This study addresses the correlation between overall NK function and trastuzumab's clinical activity... - Prostatectomy restores the maturation competence of blood dendritic cell precursors and reverses the abnormal expansion of regulatory T lymphocytesDavide Brusa
Laboratory of Tumor Immunology, San Giovanni Battista Hospital, Turin, Italy
Prostate 71:344-52. 2011..To verify the presence of deviated dendritic cell (DC) precursors and of suppressor lymphocytes (Treg) in tumor bearing prostate cancer (PCa) patients and to monitor the corrective effect of tumor ablation... - Fluoride-containing bioactive glasses inhibit pentose phosphate oxidative pathway and glucose 6-phosphate dehydrogenase activity in human osteoblastsLoredana Bergandi
Department of Genetics, Biology and Biochemistry, University of Turin, Via Santena 5 bis, Turin, Italy
Chem Biol Interact 183:405-15. 2010....